Bayer AG Valuation
| BAYRY Stock | USD 12.81 0.47 3.54% |
At this time, the firm appears to be undervalued. Bayer AG PK shows a prevailing Real Value of $14.38 per share. The current price of the firm is $12.81. Our model approximates the value of Bayer AG PK from analyzing the firm fundamentals such as Profit Margin of 0.09 %, current valuation of 87.41 B, and Return On Equity of 0.13 as well as examining its technical indicators and probability of bankruptcy. . In general, most investors favor acquiring undervalued instruments and dropping overvalued instruments since, at some point, asset prices and their ongoing real values will blend.
Undervalued
Today
Please note that Bayer AG's price fluctuation is not too volatile at this time. Calculation of the real value of Bayer AG PK is based on 3 months time horizon. Increasing Bayer AG's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Bayer otc stock is determined by what a typical buyer is willing to pay for full or partial control of Bayer AG PK. Since Bayer AG is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Bayer OTC Stock. However, Bayer AG's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 12.81 | Real 14.38 | Hype 12.81 | Naive 12.73 |
The intrinsic value of Bayer AG's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Bayer AG's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Bayer AG PK helps investors to forecast how Bayer otc stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Bayer AG more accurately as focusing exclusively on Bayer AG's fundamentals will not take into account other important factors: About Bayer AG Valuation
Our relative valuation model uses a comparative analysis of Bayer AG. We calculate exposure to Bayer AG's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Bayer AG's related companies.Bayer Aktiengesellschaft, together its subsidiaries, operates as a life science company worldwide. Bayer Aktiengesellschaft was founded in 1863 and is headquartered in Leverkusen, Germany. Bayer Aktienges is traded on OTC Exchange in the United States.
8 Steps to conduct Bayer AG's Valuation Analysis
OTC Stock's valuation is the process of determining the worth of any otc stock in monetary terms. It estimates Bayer AG's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of otc stock valuation is a single number representing a OTC Stock's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Bayer AG's valuation analysis, follow these 8 steps:- Gather financial information: Obtain Bayer AG's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Bayer AG's revenue streams: Identify Bayer AG's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Bayer AG's industry and market trends, including the size of the market, growth rate, and competition.
- Establish Bayer AG's growth potential: Evaluate Bayer AG's management, business model, and growth potential.
- Determine Bayer AG's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the OTC Stock's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Bayer AG's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Bayer AG Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
| Common Stock Shares Outstanding | 982.4 M | |
| Quarterly Earnings Growth Y O Y | 5.424 | |
| Forward Price Earnings | 6.5833 | |
| Retained Earnings | 13.3 B |
Additional Tools for Bayer OTC Stock Analysis
When running Bayer AG's price analysis, check to measure Bayer AG's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bayer AG is operating at the current time. Most of Bayer AG's value examination focuses on studying past and present price action to predict the probability of Bayer AG's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bayer AG's price. Additionally, you may evaluate how the addition of Bayer AG to your portfolios can decrease your overall portfolio volatility.